Protein Biomarkers for Breast Cancer

(The Woodlands, TX, USA) and Mercy Women's Center (Oklahoma City, OK, USA). The two groups have been collecting blood samples from women undergoing magnetic resonance imaging (MRI) of the breast. The database now accounts for the largest collection of samples tied to MRI results in the United States. The more samples tested, the more accurate the team can become in identifying specific protein biomarkers unique to women with breast cancer.

"I am encouraged by our initial discoveries utilizing blood serum to detect critical proteins associated with this devastating disease,” noted Dr. Ira Goldknopf, CSO of Power3 Medical. "We continue to believe that the key to detection of breast cancer at its earliest stages lies in the changes of one's proteins.”

Power3 Medical is engaged in the discovery of protein footprints, pathways, and mechanisms of disease that its proprietary technology can detect in patients. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease.





Related Links:
Power3 Medical
Mercy Women's Center